report better-than-expect fiscal result except
strong organ growth versu estim drive meaning
out-performance rel consensu revenu estim million
versu consensu expect million quarter compani
life scienc divis contribut upsid versu revenu
estim robust order backlog enter fiscal favor order
activ contribut growth life scienc capit equip sale
addit ste double-digit organ growth trend continu appli
steril technolog led favor market demand market share
gain sterigen well healthcar specialti servic led
double-digit growth instrument repair new outsourc reprocess
center win come on-line expect help off-set anticip
soft healthcar capit sale moreov ste revenu out-performance
help off-set weaker-than-anticip fiscal adjust
oper margin expans bp year-over-year reflect
higher incent compens expens well invest
outsourc reprocess center capac instrument repair technician
drive modest upsid adjust ep versu consensu
expect estim
follow strong fiscal rais constant currenc growth
guidanc notabl compani guidanc impli
small acquisit fiscal face tough comparison
particularli healthcar capit busi addit increas
adjust ep outlook high end prior rang
versu prior consensu expect
provid formal guidanc compani suggest
constant currenc organ growth rang reason target
rais adjust ep estim
respect increas forecast
reflect fiscal result also rais adjust
oper margin expans assumpt effort reflect like tailwind
incent compens million higher expect far
given compani upsid versu initi expect
total debt total asset
deliv anoth strong quarter fiscal compani appear
well posit maintain elev organ growth behind robust life scienc
better year equip introduct capac addit
competitor struggl appli steril encourag
custom respons outsourc reprocess center initi
reiter buy rate increas price target
import pleas read disclosur disclaim page report
report fiscal adjust ep estim higher
consensu expect quarter stronger-than-anticip revenu contribut upsid rel
adjust ep forecast
ste fiscal revenu increas year-over-year million consensu
expect million estim million quarter compani report constant
plcfiscal adjust incom statement revenu analysisnorthcoast research thousand except percentag per share gross sg sg oper oper interest expens interest net expens incom incom tax incom margin incom com share growth ep growth life appli steril healthcar specialti compani report northcoast research estim factset currenc organ growth exceed forecast driven primarili better-than-expect
result life scienc notabl exclud small acquisit ad million fiscal revenu
includ ste constant currenc organ growth metric estim compani organ growth
quarter
busi unit perspect ste healthcar product divis achiev constant currenc organ growth
posit fiscal slightli forecast exclud acquisit estim ste
healthcar organ closer roughli quarter
steri plcorgan growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research plchealthcar product organ growth analysi benefit signific year-over-year increas shipment hurt difficult year-over-year comparison shipmentssourc compani report northcoast research fiscal organ growth ste healthcar divis led roughli year-over-year growth
healthcar consum mid-single-digit improv healthcar servic help off-set flattish
organ growth perform healthcar capit notabl face difficult comparison healthcar
capit busi year follow organ growth perform last year contribut lacklust
healthcar capit sale perform quarter well low-single-digit year-over-year declin
healthcar capit backlog end fiscal product categori standpoint believ growth
ste infect prevent capit busi continu outpac oper room equip quarter
notabl mention oper room tabl light need refresh believ
like happen next year provid catalyst improv perform segment
fiscal ste life scienc busi post organ growth well estim
compani robust life scienc capit order backlog exit fiscal surpris
magnitud fiscal sale improv segment report closer organ
well continu strength life scienc capit backlog exit quarter year-over-year
aid perform late earli
ste appli steril ast busi achiev constant currenc organ growth fiscal
forecast exclud small acquisit estim compani ast organ
steri plcorder backlog analysi northcoast researchord backlog order scienc order scienc compani report northcoast research estim steri plclife scienc divis organ growth analysi compani report northcoast research growth closer addit strong medic devic market demand ste ast busi also
benefit capac expans effort well modest market share gain relat disrupt creat
temporari perman closur sever competit ethylen oxid steril facil moreov
above-averag capit spend addit ast capac expans think organ growth
divis remain least high-single-digit rang intermediate-term
ste healthcar specialti servic busi achiev constant currenc organ growth fiscal
forecast quarter compani instrument repair segment post double-digit
organ growth believ mid-single-digit rang fiscal moreov ste
outsourc reprocess center busi appear remain track would guess revenu
increas approxim million roughli million furthermor outsourc reprocess
center busi continu ramp think good visibl ste overal healthcar specialti
servic divis least grow high-single-digit rate
plcappli steril technolog divis organ growth analysissourc compani report northcoast research plchealthcar specialti servic divis organ growth analysissourc compani report northcoast research ste fiscal adjust oper margin increas bp year-over-year
estim state previous compani out-performance contribut million increas
incent compens versu initi expect also decid continu invest
outsourc reprocess center capac instrument repair technician given opportun see
busi invest limit oper margin expans shorter-term also give us
increas confid ste abil sustain elev organ growth divis
follow strong fiscal rais constant currenc growth guidanc
notabl compani guidanc impli roughli constant currenc growth includ roughli bp
benefit small acquisit fiscal face tough comparison particularli healthcar
capit busi notabl china account small percent ste revenu compani seen
notic impact far fiscal relat wuhan coronaviru
addit rais constant currenc organ growth guidanc increas adjust ep
outlook high end prior rang versu prior consensu expect compani
also continu expect cash flow oper million slightli rais free cash flow
guidanc million million reflect time capit expenditur
provid formal guidanc compani suggest constant currenc organ growth
rang reason target next year despit difficult year-over-year comparison
rais adjust ep estim respect
increas forecast reflect fiscal result also rais adjust oper
margin expans assumpt effort reflect like tailwind incent compens million
higher expect far given compani upsid versu initi expect
overal deliv anoth strong quarter fiscal compani appear well posit maintain
activ includ better year equip introduct capac addit competitor
struggl appli steril encourag custom respons outsourc
reprocess center initi reiter buy rate increas price target
plcadjust oper margin healthcar life appli steril healthcar specialti fiscal exclud corpor expensesourc compani report northcoast research
steri plcannual incom statement analysi adjust northcoast research thousand except percent per share gross gross sg sg oper oper net interest expens interest net expens incom incom incom tax minor net incom extra net margin extra extra net incom continu net wghd com share ep ep revenu growth adjust ep growth compani report northcoast research estim result adjust reflect adopt disclosur
